Clinical Trials for Streptococcus Agalactiae Infection

Find clinical trials for streptococcus agalactiae infection. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

NCT ID: NCT06592586

This clinical trial is studying a vaccine called GBS-NN/NN2, which is designed to help protect against infections caused by a type of bacteria known as Group B Streptococcus (GBS). This study will ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aarhus N, Midtjylland, Denmark, Kolding, Syddanmark, Denmark +5 more

GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age

NCT ID: NCT06494475

This clinical trial is investigating a new vaccine designed to protect against a bacterial infection called Streptococcus agalactiae (often referred to as Group B Streptococcus, or GBS). The study ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease

NCT ID: NCT04735419

This clinical trial is studying a potential vaccine to protect infants from a serious infection caused by a bacteria called Group B Streptococcus (GBS). The researchers want to understand if measur...

Recruiting

Type: observational Locations: London, , United Kingdom

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions